These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Condom use among young women who sell sex in Zimbabwe: a prevention cascade analysis to identify gaps in HIV prevention programming. Chabata ST, Hensen B, Chiyaka T, Mushati P, Busza J, Floyd S, Birdthistle I, Hargreaves JR, Cowan FM. J Int AIDS Soc; 2020 Jun; 23 Suppl 3(Suppl 3):e25512. PubMed ID: 32602611 [Abstract] [Full Text] [Related]
3. A risk-differentiated, community-led intervention to strengthen uptake and engagement with HIV prevention and care cascades among female sex workers in Zimbabwe (AMETHIST): a cluster randomised trial. Cowan FM, Machingura F, Ali MS, Chabata ST, Takaruza A, Dirawo J, Makamba M, Hove T, Bansi-Matharu L, Matambanadzo P, Shahmanesh M, Busza J, Steen R, Yekeye R, Mpofu A, Mugurungi O, Phillips AN, Hargreaves JR. Lancet Glob Health; 2024 Sep; 12(9):e1424-e1435. PubMed ID: 39151978 [Abstract] [Full Text] [Related]
4. Factors motivating female sex workers to initiate pre- exposure prophylaxis for HIV prevention in Zimbabwe. Nhamo D, Duma SE, Ojewole EB, Chibanda D, Cowan FM. PLoS One; 2022 Sep; 17(7):e0264470. PubMed ID: 35797351 [Abstract] [Full Text] [Related]
5. Comparing the impact of increasing condom use or HIV pre-exposure prophylaxis (PrEP) use among female sex workers. Mukandavire Z, Mitchell KM, Vickerman P. Epidemics; 2016 Mar; 14():62-70. PubMed ID: 26972515 [Abstract] [Full Text] [Related]
7. Key barriers and enablers associated with uptake and continuation of oral pre-exposure prophylaxis (PrEP) in the public sector in Zimbabwe: Qualitative perspectives of general population clients at high risk for HIV. Gombe MM, Cakouros BE, Ncube G, Zwangobani N, Mareke P, Mkwamba A, Prescott MR, Bhatasara T, Murwira M, Mangwiro AZ, Prust ML. PLoS One; 2020 Mar; 15(1):e0227632. PubMed ID: 31931514 [Abstract] [Full Text] [Related]
8. HIV pre-exposure prophylaxis use during periods of unprotected sex among female sex workers in Tanga city, Tanzania: a control arm analysis of the pragmatic quasi-experimental trial. Mikomangwa WP, Moen K, Mmbaga EJ, Metta E, Kibusi SM, Leshabari MT, Kamuhabwa AAR, Kwesigabo G. Front Public Health; 2024 Mar; 12():1405765. PubMed ID: 39081360 [Abstract] [Full Text] [Related]
9. Evaluating the impact of DREAMS on HIV incidence among young women who sell sex: protocol for a non-randomised study in Zimbabwe. Hensen B, Hargreaves JR, Chiyaka T, Chabata S, Mushati P, Floyd S, Birdthistle I, Busza J, Cowan F. BMC Public Health; 2018 Jan 31; 18(1):203. PubMed ID: 29386001 [Abstract] [Full Text] [Related]
10. How Can We Support the Use of Oral PrEP Among Young Women who Sell Sex? A PrEP Cascade Analysis. Hensen B, Machingura F, Busza J, Birdthistle I, Chabata ST, Chiyaka T, Floyd S, Jamali G, Mushati P, Hargreaves J, Cowan FM. J Acquir Immune Defic Syndr; 2021 Sep 01; 88(1):45-56. PubMed ID: 34050101 [Abstract] [Full Text] [Related]
11. Awareness and Interest in HIV Pre-Exposure Prophylaxis Among Street-Based Female Sex Workers: Results from a US Context. Tomko C, Park JN, Allen ST, Glick J, Galai N, Decker MR, Footer KHA, Sherman SG. AIDS Patient Care STDS; 2019 Feb 01; 33(2):49-57. PubMed ID: 30632769 [Abstract] [Full Text] [Related]
12. Targeted combination prevention to support female sex workers in Zimbabwe accessing and adhering to antiretrovirals for treatment and prevention of HIV (SAPPH-IRe): a cluster-randomised trial. Cowan FM, Davey C, Fearon E, Mushati P, Dirawo J, Chabata S, Cambiano V, Napierala S, Hanisch D, Wong-Gruenwald R, Masuka N, Mabugo T, Hatzold K, Mugurungi O, Busza J, Phillips A, Hargreaves JR. Lancet HIV; 2018 Aug 01; 5(8):e417-e426. PubMed ID: 30030134 [Abstract] [Full Text] [Related]
13. Applying the HIV Prevention Cascade to an Evaluation of a Large-Scale Combination HIV Prevention Programme for Adolescent Girls and Young Women in South Africa. Bergh K, Toska E, Duby Z, Govindasamy D, Mathews C, Reddy T, Jonas K. AIDS Behav; 2024 Apr 01; 28(4):1137-1151. PubMed ID: 37462890 [Abstract] [Full Text] [Related]
14. Alignment of PrEP adherence with periods of HIV risk among adolescent girls and young women in South Africa and Zimbabwe: a secondary analysis of the HPTN 082 randomised controlled trial. Velloza J, Donnell D, Hosek S, Anderson PL, Chirenje ZM, Mgodi N, Bekker LG, Marzinke MA, Delany-Moretlwe S, Celum C. Lancet HIV; 2022 Oct 01; 9(10):e680-e689. PubMed ID: 36087612 [Abstract] [Full Text] [Related]
15. Factors Associated with Usage of Oral-PrEP among Female Sex Workers in Nairobi, Kenya, Assessed by Self-Report and a Point-of-Care Urine Tenofovir Immunoassay. Shah P, Spinelli M, Irungu E, Kabuti R, Ngurukiri P, Babu H, Kungu M, Champions TMFS, Nyabuto C, Mahero A, Devries K, Kyegombe N, Medley GF, Gafos M, Seeley J, Weiss HA, Kaul R, Gandhi M, Beattie TS, Kimani J. AIDS Behav; 2024 Nov 01; 28(11):3836-3849. PubMed ID: 39136824 [Abstract] [Full Text] [Related]
16. Determinants of Intention to Use HIV Pre-exposure Prophylaxis and Condom Use Among a Sample of Cisgender Female Sex Workers Working Mostly Outdoors in Madrid, Spain. Vazquez Guillamet LJ, Valencia J, Ryan P, Cuevas-Tascón G, Del-Olmo-Morales MA, Cobo I, Lazarus JV, Chevance G. Arch Sex Behav; 2024 Jul 01; 53(7):2817-2831. PubMed ID: 38858230 [Abstract] [Full Text] [Related]
17. Acceptability of microbicidal vaginal rings and oral pre-exposure prophylaxis for HIV prevention among female sex workers in a high-prevalence US city. Peitzmeier SM, Tomko C, Wingo E, Sawyer A, Sherman SG, Glass N, Beyrer C, Decker MR. AIDS Care; 2017 Nov 01; 29(11):1453-1457. PubMed ID: 28271718 [Abstract] [Full Text] [Related]
18. Understanding early uptake of PrEP by female sex workers in Zimbabwe. Busza J, Phillips AN, Mushati P, Chiyaka T, Magutshwa S, Musemburi S, Cowan FM. AIDS Care; 2021 Jun 01; 33(6):729-735. PubMed ID: 33043688 [Abstract] [Full Text] [Related]
19. PrEP uptake, persistence, adherence, and effect of retrospective drug level feedback on PrEP adherence among young women in southern Africa: Results from HPTN 082, a randomized controlled trial. Celum C, Hosek S, Tsholwana M, Kassim S, Mukaka S, Dye BJ, Pathak S, Mgodi N, Bekker LG, Donnell DJ, Wilson E, Yuha K, Anderson PL, Agyei Y, Noble H, Rose SM, Baeten JM, Fogel JM, Adeyeye A, Wiesner L, Rooney J, Delany-Moretlwe S. PLoS Med; 2021 Jun 01; 18(6):e1003670. PubMed ID: 34143779 [Abstract] [Full Text] [Related]